Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 06-2017 | |
| Operating Expenses | 33,455 | 50,555 | 47,565 | 20,390 | 4,593 |
| Operating Income | -33,455 | -50,555 | -47,565 | -20,390 | -4,593 |
| Interest Expense | 0 | 0 | 0 | 0 | 265 |
| Other Income | -1,122 | -319 | 502 | -824 | -1,978 |
| Pre-tax Income | -34,577 | -50,874 | -47,063 | -21,214 | -6,836 |
| Income Tax | N/A | N/A | 122 | N/A | -1,040 |
| Net Income Continuous | -34,577 | -50,874 | -47,185 | -21,214 | -5,796 |
| Net Income | $-34,577 | $-50,874 | $-47,185 | $-21,214 | $-5,796 |
| EPS Basic Total Ops | -34.40 | -53.60 | -58.00 | -190.00 | -10.80 |
| EPS Basic Continuous Ops | -34.47 | -53.46 | -58.19 | -170.53 | -9.99 |
| EPS Diluted Total Ops | -34.40 | -53.60 | -58.00 | -190.00 | -10.80 |
| EPS Diluted Continuous Ops | -34.47 | -53.46 | -58.19 | -170.53 | -9.99 |
| EPS Diluted Before Non-Recurring Items | -34.40 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-32,306 | $-49,762 | $-47,349 | $-19,683 | $-4,549 |